Aveed’s Impact on Lipid Profiles and Insulin Sensitivity in Hypogonadal Men: 18-Month Study
Reading Time: 2 minutesIntroduction Aveed, a testosterone undecanoate injection developed by Endo Pharmaceuticals, has been a significant therapeutic option for testosterone replacement therapy in hypogonadal men. As its use becomes more widespread, understanding its long-term effects on metabolic parameters such as lipid profiles and insulin sensitivity is crucial. This article delves into a comprehensive 18-month study focused on American males, aiming to shed... Read more »